CLOMIPRAMINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Clomipramine Hydrochloride, and what generic alternatives are available?
Clomipramine Hydrochloride is a drug marketed by Ajanta Pharma Ltd, Alembic, Amneal Pharms Co, Aurobindo Pharma, Chemistry Hlth, Jubilant Cadista, Lupin Ltd, Mankind Pharma, Micro Labs, Mylan, Rk Pharma, Sandoz, Taro, Teva, Tulex Pharms Inc, Unique, Watson Labs, and Zydus Pharms. and is included in twenty-one NDAs.
The generic ingredient in CLOMIPRAMINE HYDROCHLORIDE is clomipramine hydrochloride. There are eleven drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the clomipramine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Clomipramine Hydrochloride
A generic version of CLOMIPRAMINE HYDROCHLORIDE was approved as clomipramine hydrochloride by SANDOZ on March 29th, 1996.
Summary for CLOMIPRAMINE HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 18 |
NDAs: | 21 |
Finished Product Suppliers / Packagers: | 25 |
Raw Ingredient (Bulk) Api Vendors: | 123 |
Clinical Trials: | 23 |
Patent Applications: | 1,315 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in CLOMIPRAMINE HYDROCHLORIDE? | CLOMIPRAMINE HYDROCHLORIDE excipients list |
DailyMed Link: | CLOMIPRAMINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for CLOMIPRAMINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Roma La Sapienza | Phase 3 |
Fidia Farmaceutici s.p.a. | Phase 4 |
Assiut University | Phase 3 |
Pharmacology for CLOMIPRAMINE HYDROCHLORIDE
Drug Class | Tricyclic Antidepressant |